Bluechiip Limited (ASX:BCT) is a publicly listed company on the Australian Stock Exchange focused on commercializing it’s unique and patented technology and advanced sample management solution.
Bluechiip listed on the ASX in June 2011. Since then, we have significantly developed our technology. Today it has applications in healthcare, including in cryogenic storage facilities (biobanks and biorepositories), pathology, clinical trials and forensics. Other key markets include cold-chain logistics/supply chain, security/defence, industrial/manufacturing and aerospace/aviation. Bluechiip: Delivering confidence in every sample.
Bluechiip understands that every biological sample – stem cells, blood, eggs, sperm and other biospecimens – is critical, so our objective is to manage each one with optimal quality in the most efficient way.
Bluechiip’s advanced sample management solution is the only one that provides sample temperature with ID in cryogenic environments, driving productivity and improving quality. Bluechiip’s solution delivers confidence in every sample.
Download Bluechiip’s most recent Annual reports from the links below: